Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Sinopharm Group Co., Ltd.    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
End-of-day quote. End-of-day quote Hong Kong Stock Exchange - 08/06
18.98 HKD   -1.25%
08/04Brazil, hotbed for COVID-19 vaccine testing, may struggle to produce its own
RE
08/04SINOPHARM : Closure of the register of members
PU
07/30A BIG OBSTACLE : Where can CanSino test its vaccine abroad?
RE
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
07/31/2020 08/03/2020 08/04/2020 08/05/2020 08/06/2020 Date
18.46 19 19.16 19.22 18.98 Last
6722918 14810850 12105950 5363043 8866067 Volume
-0.54% +2.93% +0.84% +0.31% -1.25% Change
Financials
Sales 2020 462 B 66 677 M 66 677 M
Net income 2020 6 548 M 944 M 944 M
Net Debt 2020 14 997 M 2 162 M 2 162 M
P/E ratio 2020 8,88x
Yield 2020 3,40%
Sales 2021 528 B 76 113 M 76 113 M
Net income 2021 7 455 M 1 075 M 1 075 M
Net Debt 2021 24 030 M 3 465 M 3 465 M
P/E ratio 2021 7,81x
Yield 2021 3,76%
Capitalization 59 941 M 7 734 M 8 643 M
EV / Sales 2020 0,16x
EV / Sales 2021 0,16x
Nbr of Employees 93 764
Free-Float 43,0%
More Financials
Company
Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical products to hospitals, other distributors, retail drug stores and clinics. The Retail Pharmacy segment is engaged in... 
More about the company
Surperformance© ratings of Sinopharm Group Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on SINOPHARM GROUP CO., LTD.
08/04Brazil, hotbed for COVID-19 vaccine testing, may struggle to produce its own
RE
08/04SINOPHARM : Closure of the register of members
PU
07/30A BIG OBSTACLE : Where can CanSino test its vaccine abroad?
RE
07/30A BIG OBSTACLE : Where can CanSino test its vaccine abroad?
RE
07/30China, HK stocks steady as Fed dovish stance aids sentiment
RE
07/29China's Sinopharm to test potential COVID-19 vaccine in Brazil
RE
07/28SINOPHARM : Continuing connected transactions entering into the procurement fram..
PU
07/24SINOPHARM : Voluntary announcement acquisition of 100% equity in chengda fangyua..
PU
07/24NEWS HIGHLIGHTS : Top Global Markets News of the Day
DJ
07/24NEWS HIGHLIGHTS : Top Global Markets News of the Day
DJ
07/24NEWS HIGHLIGHTS : Top Global Markets News of the Day
DJ
07/23NEWS HIGHLIGHTS : Top Global Markets News of the Day
DJ
07/23NEWS HIGHLIGHTS : Top Global Markets News of the Day
DJ
07/23China's Sinopharm says coronavirus vaccine could be ready by year-end - state..
RE
07/23China's Sinopharm says coronavirus vaccine could be ready by year-end - state..
RE
More news
News in other languages on SINOPHARM GROUP CO., LTD.
08/04Brazil, hotbed for COVID-19 vaccine testing, may struggle to produce its own
08/04SINOPHARM : Closure of the register of members
07/30A BIG OBSTACLE : Where can CanSino test its vaccine abroad?
07/30A BIG OBSTACLE : Where can CanSino test its vaccine abroad?
07/30Borsa Shanghai in calo su prese profitto, settori tech, estrattivo guidano ca..
More news
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 24,27 CNY
Last Close Price 19,22 CNY
Spread / Highest target 101%
Spread / Average Target 26,3%
Spread / Lowest Target -25,9%
EPS Revisions
Managers
NameTitle
Yong Liu President & Executive Director
Fang Yao Chairman-Supervisory Board
Zhi Ming Li Chairman
Xiu Chang Jiang Chief Financial Officer & Vice President
Jin Dong Deng Non-Executive Director
Sector and Competitors